The New Era of Precision Diagnostics
Modern hospitals are increasingly embracing molecular and liquid biopsy technologies to improve diagnostic accuracy and patient outcomes. However, traditional methods for isolating and analyzing biomarkers — especially extracellular vesicles (EVs) — remain slow, expensive, and logistically complex.
At Acytronix, we are redefining this process with our breakthrough device: PMED – the Portable Microstructured Electrochemical Device for rapid purification of extracellular vesicles.
Why Extracellular Vesicles Matter
Extracellular vesicles are tiny biological particles released by nearly all cells. They carry valuable information — proteins, lipids, and nucleic acids — that reflect the condition of their originating tissues.
For hospitals, this means EVs can serve as non-invasive biomarkers for a wide range of diseases, including cancer, cardiovascular, and neurological disorders.
Yet, despite their diagnostic potential, the traditional EV purification process has been a major barrier to clinical adoption. Conventional ultracentrifugation and filtration require:
- Expensive, bulky laboratory equipment
- Highly skilled technicians
- Hours to days of processing time
- Large sample volumes and complex logistics
These challenges make large-scale EV analysis impractical for many hospital laboratories.
PMED: A Rapid, Reliable, and Cost-Efficient Solution
PMED overcomes these limitations by enabling EV purification in under 10 minutes, directly from plasma, serum, urine, or other physiological fluids — without ultracentrifugation or bulky instruments.
Using immunoaffinity capture and an electrochemical release mechanism, PMED selectively isolates EVs of interest based on key surface markers (such as CD9, CD63, and CD73) — achieving results that are cleaner, faster, and more reproducible than any existing method.
Key Benefits for Hospitals and Diagnostic Centers:
✅ Reduce Costs and Downtime
No need for high-speed centrifuges or complex filtration systems. The simplified workflow lowers capital and operational expenses.
✅ Faster Results
EV purification and analysis can now be completed within minutes — enabling same-day insights for clinical decision-making.
✅ Simplified Logistics
Compact and portable, PMED eliminates the need for centralized sample processing. Hospitals can perform EV-based analysis on-site, reducing transportation and storage challenges.
✅ High Purity and Reliability
PMED’s antibody-based capture ensures selective enrichment of EVs, free from lipoprotein contamination, delivering consistent and clinically relevant data.
✅ Scalable for Research and Diagnostics
From research laboratories to clinical diagnostics, PMED provides a standardized and reproducible EV purification method adaptable to any workflow.
Clinical Applications and Collaboration Opportunities
Hospitals adopting PMED can significantly enhance their liquid biopsy programs and biomarker discovery pipelines. The technology enables:
- Early disease detection through EV-based molecular profiling
- Therapy monitoring via non-invasive sample testing
- Personalized medicine supported by real-time patient data
Our technology has already demonstrated success in research published in Advanced Materials, showing clear differentiation of EV profiles between healthy and diseased models.
Trusted by Research Centers Worldwide
Acytronix has collaborated with several research institutions worldwide, where the PMED device has been successfully used for the isolation of extracellular vesicles from plasma, milk, and cell culture media. Researchers noted its ease of use, consistency, and the ability to obtain high-purity results in just minutes. These collaborations highlight PMED’s practical value in simplifying EV purification and supporting faster, more reliable outcomes in both research and diagnostic environments.
Join the Future of Hospital Diagnostics
With PMED, Acytronix bridges the gap between cutting-edge nanotechnology and practical clinical use.
Hospitals that integrate PMED into their diagnostic workflows not only reduce operational costs and complexity, but also gain access to faster, cleaner, and more reliable biomarker data.
It’s time to move beyond traditional diagnostics and embrace the next generation of EV-based precision medicine.
💡 Partner with Acytronix to bring rapid, high-quality EV purification into your hospital — and revolutionize the way diagnostics are done.
